Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Aging (Bridge Funding)

University of British Columbia

$100,000.00

Studies on p97 (Melanotransferrin)

FY 2008-09

Summary
Iron is critical for life. However, iron can contribute to disease if it not directly held under check. For example, it is known that iron can lead to damage in the brains of Alzheimer's disease (AD) patients. AD is a progressive and fatal brain disease that is the most common form of dementia (loss of memory and other intellectual abilities relating to daily life). There is no cure and diagnosis can only be confirmed after death. A hallmark of the disease are deposits in the brain made up of protein fragments called amyloid-beta. It is believed that Abeta is one factor directly responsible for killing the brain. The build up iron in and around these plaques is believed to make the disease even worse. A protein that binds iron, called melanotransferrin (p97), might play an important role in AD because it can affect how iron gets delivered to the brain. We believe that p97 plays a very important role in AD but this exact relationship is not very clear. The p97 protein may one day be used to diagnose patients for AD faster and thus start treatment sooner. However, to do this we want to clarify how, when and where p97 functions under normal and disease conditions. To do this, we will study where p97 is in relation to other features found only in the brains of AD patients using powerful microscopes. Next, we will study the biology of p97 using a genetically engineered mouse to see what happens when you remove p97 from a living organism. Finally, to study how big of a role that p97 plays in AD, we will make a special mouse that has Alzheimer's like disease but can't make p97. If p97 does play an important role in AD, then this information will help make faster and more accurate diagnosis for AD. Currently, the only to make 100% sure that someone had AD is to look at the brain after death. A faster diagnosis means treatment can be begin sooner.
Program
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
176152
Name
Jefferies Wilfred A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Studies on p97 (Melanotransferrin)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Keyworddelim
Alzheimer'S Disease; Inflammation; Iron; Microglia; Oxidative Radicals; P97
Abstract
Iron is critical for life. However, iron can contribute to disease if it not directly held under check. For example, it is known that iron can lead to damage in the brains of Alzheimer's disease (AD) patients. AD is a progressive and fatal brain disease that is the most common form of dementia (loss of memory and other intellectual abilities relating to daily life). There is no cure and diagnosis can only be confirmed after death. A hallmark of the disease are deposits in the brain made up of protein fragments called amyloid-beta. It is believed that Abeta is one factor directly responsible for killing the brain. The build up iron in and around these plaques is believed to make the disease even worse. A protein that binds iron, called melanotransferrin (p97), might play an important role in AD because it can affect how iron gets delivered to the brain. We believe that p97 plays a very important role in AD but this exact relationship is not very clear. The p97 protein may one day be used to diagnose patients for AD faster and thus start treatment sooner. However, to do this we want to clarify how, when and where p97 functions under normal and disease conditions. To do this, we will study where p97 is in relation to other features found only in the brains of AD patients using powerful microscopes. Next, we will study the biology of p97 using a genetically engineered mouse to see what happens when you remove p97 from a living organism. Finally, to study how big of a role that p97 plays in AD, we will make a special mouse that has Alzheimer's like disease but can't make p97. If p97 does play an important role in AD, then this information will help make faster and more accurate diagnosis for AD. Currently, the only to make 100% sure that someone had AD is to look at the brain after death. A faster diagnosis means treatment can be begin sooner.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jefferies, Wilfred A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~